The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease

被引:75
|
作者
Pimentel-Coelho, Pedro M.
Rivest, Serge [1 ]
机构
[1] Univ Laval, CHUQ Res Ctr CHUL, Lab Endocrinol & Genom, Quebec City, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
angiogenesis; cerebral ischemia; chronic cerebral hypoperfusion; neurogenesis; stroke; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; WHITE-MATTER LESIONS; CIRCULATING ANGIOGENIC CELLS; CAROTID-ARTERY OCCLUSION; MARROW-DERIVED MICROGLIA;
D O I
10.1111/j.1460-9568.2012.08126.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimers disease (AD) and cerebrovascular disorders are the leading causes of dementia in our ageing population. Given that the progression of neuropathological changes in the brains of AD patients initiates several years, and even decades, before the diagnosis of dementia, a great effort has been made to identify potentially modifiable factors that contribute to the pathogenesis of sporadic late-onset AD. Among these factors, cerebrovascular disease and microvascular alterations seem to bilaterally interact with the underlying AD pathology, affecting the progression of cognitive deficits. In addition, cerebrovascular dysfunction has emerged as an early event in AD, encompassing changes in virtually all cell types of the neurovascular unit, including bone marrow-derived cells, astrocytes, pericytes, vascular smooth muscle cells and endothelial cells. In this review, we discuss recent studies implicating cerebrovascular factors in the pathogenesis of AD. We also discuss how the impairment of mechanisms of brain regeneration, such as neurogenesis and angiogenesis, might be related to the vascular dysfunction. Finally, we briefly discuss several therapeutic options targeting the vascular system, which might represent an interesting strategy for preventing or delaying the onset of dementia in AD.
引用
收藏
页码:1917 / 1937
页数:21
相关论文
共 50 条
  • [21] Early Stages of Pathogenesis in Memory Impairment during Normal Senescence and Alzheimer's Disease
    Daulatzai, Mak Adam
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (02) : 355 - 367
  • [22] Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
    Chakrabarti, Sasanka
    Khemka, Vineet Kumar
    Banerjee, Anindita
    Chatterjee, Gargi
    Ganguly, Anirban
    Biswas, Atanu
    AGING AND DISEASE, 2015, 6 (04): : 282 - 299
  • [23] Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT
    Declercq, Lieven D.
    Vandenberghe, Rik
    Van Laere, Koen
    Verbruggen, Alfons
    Bormans, Guy
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [24] Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches
    Ejaz, Hafza Wajeeha
    Wang, Wei
    Lang, Minglin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 33
  • [25] Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease
    Yassi, Nawaf
    Hilal, Saima
    Xia, Ying
    Lim, Yen Ying
    Watson, Rosie
    Kuijf, Hugo
    Fowler, Christopher
    Yates, Paul
    Maruff, Paul
    Martins, Ralph
    Ames, David
    Chen, Christopher
    Rowe, Christopher C.
    Villemagne, Victor L.
    Salvado, Olivier
    Desmond, Patricia M.
    Masters, Colin L.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 897 - 907
  • [26] Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls
    Lithgow, Brian J.
    Dastgheib, Zeinab
    Anssari, Neda
    Mansouri, Behzad
    Blakley, Brian
    Ashiri, Mehrangiz
    Moussavi, Zahra
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2021, 59 (7-8) : 1597 - 1610
  • [27] Alzheimer's disease: from early pathogenesis to novel therapeutic approaches
    Prajapati, Santosh Kumar
    Pathak, Arjit
    Samaiya, Puneet K.
    METABOLIC BRAIN DISEASE, 2024, 39 (06) : 1231 - 1254
  • [28] APOE and Alzheimer's Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
    Brandon, Jason A.
    Farmer, Brandon C.
    Williams, Holden C.
    Johnson, Lance A.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [29] Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
    Honjo, Kie
    Black, Sandra E.
    Verhoeff, Nicolaas P. L. G.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (06) : 712 - 728
  • [30] Retrograde Memory in Cerebrovascular Disease and Alzheimer's Disease
    Capruso, Daniel X.
    Hamsher, Kerry deS.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (04) : 265 - 274